clothiapine has been researched along with Insulin Sensitivity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujita, S; Fujiwara, T; Hagisawa, Y; Isobe, A; Takamura, M; Yachi, M; Yamada, E; Yanagisawa, H | 1 |
| Ardecky, RJ; Boehm, MF; Chen, JH; Crombie, DL; Etgen, GJ; Faul, MM; Faulkner, AL; Grese, TA; Heyman, RA; Karanewsky, DS; Klausing, K; Leibowitz, MD; Liu, S; Mais, DA; Mapes, CM; Marschke, KB; Michellys, PY; Ogilvie, KM; Reifel-Miller, A; Rungta, D; Thompson, AW; Tyhonas, JS | 1 |
2 other study(ies) available for clothiapine and Insulin Sensitivity
| Article | Year |
|---|---|
Novel oximes having 5-benzyl-2,4-thiazolidinedione as antihyperglycemic agents: synthesis and structure-activity relationship.
Topics: Animals; Blood Glucose; Drug Evaluation; Hyperglycemia; Hypoglycemic Agents; Insulin Resistance; Isomerism; Mice; Mice, Inbred Strains; Oximes; Receptors, Cytoplasmic and Nuclear; Structure-Activity Relationship; Thiazoles; Transcription Factors | 2000 |
Novel (2E,4E,6Z)-7-(2-alkoxy-3,5-dialkylbenzene)-3-methylocta-2,4,6-trienoic acid retinoid X receptor modulators are active in models of type 2 diabetes.
Topics: Animals; Blood Glucose; Caprylates; Diabetes Mellitus, Type 2; Hypoglycemic Agents; Insulin Resistance; Male; Mice; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Retinoic Acid; Retinoid X Receptors; Structure-Activity Relationship; Transcription Factors | 2003 |